Baris Turkbey, Head of the Magnetic Resonance Imaging section in MIB, shared post on X:
“Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer: From CHAARTED to PSMA PET-An International Multicenter Retrospective Study
– Compared with conventional imaging, addition of PSMA PET leads to M0 downstaging in every third and LVD to HVD upstaging in every fifth metastatic hormone-sensitive prostate cancer patient.
– Future HVD and LVD definitions based on PSMA PET/CT should be adjusted based on patient outcome.”
